MiniMed: High Energy Model for Growth

MiniMed is riding a wave of success, with its external insulin pump business growing 30% a year, and its continuous glucose monitor in the final stages of the FDA approval process. With so many device companies stumbling in the race to find better ways to treat diabetes, why is MiniMed flourishing?